PTE: Supports Utah Biotech & Life Sci Community

PolarityTE chose to establish its headquarters in Utah because of the incredible opportunity to join a thriving and rapidly growing life science ecosystem. In less than two years, the Company has grown from a few doctors and scientists who initially left academic medicine to build the company, to more than 120 employees – most of whom were pulled from the impressive talent in Utah. PolarityTE values the collaborative business environment in Utah and appreciates the opportunities to connect with entities including the University of Utah, and state and local governments. Recently, PolarityTE leaders participated in the Governor's Trade Mission to South Korea and Taiwan to explore opportunities for PolarityTE to expand into international markets.

Also, earlier this month, PolarityTE hosted Salt Lake City Mayor Jackie Biskupski at the PolarityTE Central Campus to discuss opportunities to work together to further develop the Salt Lake City biotech community. Through efforts like these and as members of BioUtah, the Company will continue to support the Utah life science community and BioUtah's goals of attracting and retaining life sciences talent and expanding the industry's presence and Utah's position on the global map of biotech hubs.

During the summit, PolarityTE will interact with other industry leaders, entrepreneurs, investors, economic analysts, educators and policy makers from the state. The Company has also sponsored the morning session, which will include discussions of how industry can influence lives of patients earlier, more effectively and more affordably.

"The Utah Life Sciences Summit will give us the opportunity to connect with other leaders and companies in Utah in a meaningful way. As we continue to grow, it is important for us to contribute as impactful corporate citizens in the state. Utah has helped PolarityTE thrive, and we look forward to ongoing and productive involvement as members of the community here," said Denver M. Lough, MD, PhD, Chairman and Chief Executive Officer of PolarityTE.

PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The PolarityTE platform technology begins with a small piece of the patient's own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patient's own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patient's own tissue and uses the patient's own body to support the regenerative process to create the same tissue from which it was derived. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.